Blood disorder patient registry for all ages
Part of Blood & lymphatic, Bones, joints & muscles, Genetic & congenital, Heart & circulation clinical trials.
This study is a registry (a large database) that collects information from people who have or may have a blood disorder. It helps researchers learn more about these conditions and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child have been checked for a possible blood disorder.
- You were seen at a special center that works with the ATHN network.
- You (or a parent or legal guardian) can give permission to join the registry.
- You can be any age—children and adults are welcome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with inherited or acquired non-cancer blood disorders to better understand symptoms, causes, and how different treatments work over time. You may be placed into a disorder-specific group, depending on your diagnosis and testing results.
This study is a registry that collects information about people with bleeding disorders like hemophilia A or B and von Willebrand disease. The goal is to better understand these conditions and improve care across participating treatment centers.
This study is building a registry of people with rare blood diseases. By joining, you help doctors learn more about these conditions and improve future care.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This trial is a research registry that enrolls children with hemophilia A or B to collect health information. It may help researchers better understand bleeding risk and treatment needs over time.
This trial collects and studies blood samples from people with blood disorders. It may help researchers better understand blood conditions using lab testing rather than a new medication.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.